◆英語タイトル:University of Glasgow - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013577
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
University of Glasgow (UOG) is an educational and research institute that offers undergraduate, post graduate, and online programs. The institute operates through its departments for law, medicine, veterinary medicine and dentistry. It offers courses across various disciplines that include aeronautical engineering; accountancy and finance; biochemistry; economics, electronic and software engineering among others. UOG conducts research in the areas of precision medicine, quantum technologies, nanotechnology, sensor systems, digital humanities and many other areas. The institute also offers a wide range of high technology service supported by its research and knowledge. UOG is headquartered in Glasgow, the UK.
University of Glasgow – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Glasgow, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Glasgow, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Glasgow, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Glasgow, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Glasgow, Medical Devices Deals, 2011 to YTD 2017 9
University of Glasgow, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Glasgow, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Fixed Phage Secures Venture Financing 11
Partnerships 12
The Institute Of Microelectronics, Agency For Science Enters Into Research Agreement With University Of Glasgow 12
Licensing Agreements 13
miRagen Therapeutics Enters Into Licensing Agreement With University of Glasgow 13
University of Glasgow – Key Competitors 14
University of Glasgow – Key Employees 15
University of Glasgow – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Sep 29, 2016: University of Glasgow to share in £17.7 million funding for new healthcare technologies research 17
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 18
Aug 12, 2016: Major grant awarded to new professor to discover how to design new medicines for the treatment of Alzheimer’s Disease 20
Jan 07, 2016: Cognitive Behaviour Therapy offers long-term benefits for people with depression 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
University of Glasgow, Pharmaceuticals & Healthcare, Key Facts 2
University of Glasgow, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Glasgow, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Glasgow, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Glasgow, Deals By Therapy Area, 2011 to YTD 2017 8
University of Glasgow, Medical Devices Deals, 2011 to YTD 2017 9
University of Glasgow, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Fixed Phage Secures Venture Financing 11
The Institute Of Microelectronics, Agency For Science Enters Into Research Agreement With University Of Glasgow 12
miRagen Therapeutics Enters Into Licensing Agreement With University of Glasgow 13
University of Glasgow, Key Competitors 14
University of Glasgow, Key Employees 15